UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000036590 |
|---|---|
| Receipt number | R000041627 |
| Scientific Title | Efficacy test of supplements containing plant extract for Japanese |
| Date of disclosure of the study information | 2020/05/08 |
| Last modified on | 2019/05/15 09:48:31 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Efficacy test of supplements containing plant extract for Japanese
Acronym
Efficacy test of supplements containing plant extract for Japanese
Scientific Title
Efficacy test of supplements containing plant extract for Japanese
Scientific Title:Acronym
Efficacy test of supplements containing plant extract for Japanese
Region
| Japan |
Condition
Condition
Healthy Japanese adult
Classification by specialty
| Adult |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
The objective of this study is to verify the effects on body fat of test foods in adult men and women of BMI 25 and under 30 and abdominal visceral fat area (VFA) 80 cm^2.
Basic objectives2
Safety,Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Body fat percentage and change
Neutral fat and change
Key secondary outcomes
Weight and change
BMI and change
Waist circumference and change
Hip circumference and amount of change
Base
Study type
Interventional
Study design
Basic design
Parallel
Randomization
Randomized
Randomization unit
Individual
Blinding
Double blind -all involved are blinded
Control
Placebo
Stratification
YES
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
2
Purpose of intervention
Treatment
Type of intervention
| Food |
Interventions/Control_1
Intake of plant extract-containing food for 12 weeks
Interventions/Control_2
Intake of plant extract free food for 12 weeks
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 20 | years-old | <= |
Age-upper limit
| 64 | years-old | >= |
Gender
Male and Female
Key inclusion criteria
1) Persons aged 20 to 65 years of age at the time of obtaining informed consent
2) A healthy person who is not currently treating any disease
3) Persons with BMI of 25.0 kg / m2 or more and less than 30.0 kg / m2 at screening
4) Persons with a VFA of 80 cm2 or more using a CT scanner system
5) Those who can visit the designated medical institution on the scheduled examination date
6) A person who agreed in writing after fully understanding the purpose and content of this study
Key exclusion criteria
1) Those who have difficulty participating in the study due to liver, kidney, heart disease, respiratory disorder, endocrine disorder, metabolic disorder, neurological disorder, consciousness disorder, diabetes (according to the criteria established by the Japan Diabetes Association), and other diseases.
2) Person with a history of cardiovascular disease
3) Those who are taking glucose metabolism, lipid metabolism, blood pressure improvement drugs
4) Those who regularly use medicines and health foods / supplements (including foods for specified health, functional labeling foods and nutritionally functional foods) that may affect this study (but stop taking it at the time of obtaining consent) The person who can do it does not correspond)
5) Persons who have allergies related to the test food
6) Those who have experienced poor mood or physical condition by blood collection in the past
7) Those who donated more than 200 mL from the month before the start of the test to the start of the test
8) Those who are participating in other clinical trials or within 4 weeks after the trial
9) Alcoholic drinkers and excessive smokers
10) Eating habits are extremely irregular
11) Those who wish to become pregnant during the study period, pregnant women (including those who may be pregnant) or those who are lactating
12) Those who can not agree with the purpose of the description of this exam that is conducted in advance
In addition, those who were judged inappropriate for this study by the study investigator
Target sample size
40
Research contact person
Name of lead principal investigator
| 1st name | Yoshiaki |
| Middle name | |
| Last name | Shiojima |
Organization
RYUSENDO CO., LTD.
Division name
President and CEO
Zip code
171-0021
Address
1-5-3 Nishi-ikebukuro, Toshima-ku, Tokyo 171-0021, Japan
TEL
03-3985-8346
y.shiojima@ryusendo.co.jp
Public contact
Name of contact person
| 1st name | Megumi |
| Middle name | |
| Last name | Takahashi |
Organization
RYUSENDO CO., LTD.
Division name
Development Office
Zip code
171-0021
Address
1-5-3 Nishi-ikebukuro, Toshima-ku, Tokyo 171-0021, Japan
TEL
03-3985-8346
Homepage URL
m.takahashi@ryusendo.co.jp
Sponsor or person
Institute
KYOWA TRIAL CO., LTD
Institute
Department
Personal name
Funding Source
Organization
RYUSENDO CO., LTD.
Organization
Division
Category of Funding Organization
Profit organization
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Akanuma Surgeon Board Ethics Review Committee
Address
Ishiyama 2-jo 6-chome 14-1, Minami-ku, Sapporo-shi, Hokkaido
Tel
011-591-1777
s-ito@kyowa-t.com
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
赤沼外科医院（北海道）
Other administrative information
Date of disclosure of the study information
| 2020 | Year | 05 | Month | 08 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
0
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Terminated
Date of protocol fixation
| 2019 | Year | 03 | Month | 25 | Day |
Date of IRB
| 2019 | Year | 03 | Month | 26 | Day |
Anticipated trial start date
| 2019 | Year | 05 | Month | 20 | Day |
Last follow-up date
| 2019 | Year | 08 | Month | 31 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Management information
Registered date
| 2019 | Year | 04 | Month | 24 | Day |
Last modified on
| 2019 | Year | 05 | Month | 15 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000041627
